FLGT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
FLGT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2025-04-27), Fulgent Genetics's Intrinsic Value: Projected FCF is $95.16. The stock price of Fulgent Genetics is $18.88. Therefore, Fulgent Genetics's Price-to-Intrinsic-Value-Projected-FCF of today is 0.2.
The historical rank and industry rank for Fulgent Genetics's Intrinsic Value: Projected FCF or its related term are showing as below:
During the past 11 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Fulgent Genetics was 1.31. The lowest was 0.19. And the median was 0.30.
The historical data trend for Fulgent Genetics's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fulgent Genetics Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
Intrinsic Value: Projected FCF | Get a 7-Day Free Trial |
![]() |
![]() |
- | 76.76 | 99.59 | 99.09 | 95.16 |
Fulgent Genetics Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Intrinsic Value: Projected FCF | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
99.09 | 99.37 | 97.86 | 94.30 | 95.16 |
For the Diagnostics & Research subindustry, Fulgent Genetics's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Fulgent Genetics's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Fulgent Genetics's Price-to-Projected-FCF falls into.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)
In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):
Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)
Add all the Free Cash Flow together and divide 6 will get Fulgent Genetics's Free Cash Flow(6 year avg) = $135.28.
Fulgent Genetics's Intrinsic Value: Projected FCF for today is calculated as
Intrinsic Value: Projected FCF | = | (Growth Multiple | * | Free Cash Flow (6 year avg) | + | Total Stockholders Equity (Dec24) | * | 0.8) | / | Shares Outstanding (Diluted Average) |
= | (14.862653310476 | * | 135.28112 | + | 1133.228 | * | 0.8) | / | 30.655 | |
= | 95.16 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fulgent Genetics (NAS:FLGT) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Fulgent Genetics's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF | = | Share Price | / | Intrinsic Value: Projected FCF |
= | 18.88 | / | 95.162902822146 | |
= | 0.20 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Fulgent Genetics's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Paul Kim | officer: CFO and Treasurer | 4399 SANTA ANITA AVE, EL MONTE CA 91731 |
Hanlin Gao | 10 percent owner, officer: Chief Scientific Officer | 4399 SANTA ANITA AVE., EL MONTE CA 91731 |
Jian Xie | officer: Chief Operating Officer | C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVE, EL MONTE CA 91731 |
Ming Hsieh | director, 10 percent owner, officer: President and CEO | 4399 SANTA ANITA AVE., EL MONTE CA 91731 |
Regina E Groves | director | 5751 COPLEY DRIVE, SAN DIEGO CA 92111 |
Leonard E Post | director | |
Michael Nohaile | director | C/O BIO AI ACCELERATION COMPANY, 20 UNIVERSITY AVENUE, CAMBRIDGE MA 02138 |
John C Bolger | director | 4978 SANTA ANITA AVENUE, SUITE 205, TEMPLE CITY CA 91780 |
Ming Hsieh Trust | 10 percent owner | 4399 SANTA ANITA AVE., EL MONTE CA 91731 |
Linda Marsh | director | 100 N. STONEMAN AVE., ROOM 200, ALHAMBRA CA 91801 |
Fulgent Genetics, Inc. | director | 4399 SANTA ANITA AVE, EL MONTE CA 91731 |
Yun Yen | director | 1301 OAKLAWN ROAD, ARCADIA CA 91006 |
James Mulay | director | 6521 THOROUGHBRED LOOP, ODESSA FL 33556 |
Xi Long Usa, Inc. | 10 percent owner | #6 XINRUI RD., SCIENCE CITY, LUOGANG DISTRICT, GUANGZHOU CITY F4 510663 |
From GuruFocus
By GuruFocus News • 11-09-2024
By GuruFocus News • 11-14-2024
By Business Wire • 02-06-2025
By GuruFocus News • 04-10-2025
By GuruFocus Research • 09-20-2024
By GuruFocus News • 11-20-2024
By GuruFocus News • 01-14-2025
By Business Wire • 11-08-2024
By Business Wire • 07-11-2024
By Business Wire • 11-05-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.